Skip to main content
. Author manuscript; available in PMC: 2015 Oct 27.
Published in final edited form as: J Am Coll Surg. 2013 Mar 21;216(6):1070–1081. doi: 10.1016/j.jamcollsurg.2013.01.007

Figure 3.

Figure 3

Probability of (A) disease-free and (B) overall survival by response to neoadjuvant therapy and visceral to subcutaneous fat area ratio (V/S). (A) Patients with partial/no response (PR/NR) to neoadjuvant therapy with high V/S had the poorest disease-free survival compared with patients with compete response (CR) or those with partial/no response (PR/NR) that had low V/S (p = 0.03). (B) Similarly, PR/NR patients with high V/S appeared to have the poorest overall survival compared with others, but the differences among groups were not statistically significant (p = 0.32).